GHK-Cu + Tirzepatide
Copper Peptide Protocols, Stacking Strategies & Published Research — June 2026
1. Why People Combine Them
The #1 reason people stack GHK-Cu with tirzepatide (or other GLP-1 drugs) is skin elasticity during weight loss. GLP-1 drugs cause rapid fat loss, which often leads to loose/sagging skin. GHK-Cu is added to stimulate collagen and elastin production in hopes of preventing this.
Community Report
One Reddit user in r/TirzepatideRX reported losing 82 lbs with zero sagging skin using tirzepatide + GHK-Cu, while their brother (2 years younger, no GHK-Cu, lost weight the old-fashioned way) had significant sagging after losing 52 lbs. Genetics are similar; the peptide difference is the variable.
Other reasons people stack them:
- Anti-inflammatory support during weight loss
- Hair health (GHK-Cu stimulates follicle growth)
- General longevity and cellular repair
- Wound healing / post-surgical recovery
2. Community Protocols
Standard Subq Dosage (Reddit Consensus)
| Goal | Daily Dose | Schedule |
|---|
| Anti-aging / skin | 1–2 mg | 5 days on, 2 off |
| Longevity | 2–3 mg | 5 days on, 2 off |
| Wound healing | 2–4 mg | Continuous with breaks |
Important
These doses are community consensus, not evidence-based. No dose-finding studies exist for subcutaneous GHK-Cu in humans.
Anela Protocol (Most Popular)
Developed by a community member named Anela. The key innovation is mixing GHK-Cu with BPC-157, which dramatically reduces the sting.
- Reconstitute: 50mg GHK-Cu + 10mg BPC-157 + 3mL bacteriostatic water
- Dose: Inject ~10.5 units on an insulin syringe
- Yield: ~1.7mg GHK-Cu + 350mcg BPC-157 per injection
- After injection: Use a massage gun on the site for 2–5 minutes
- Schedule: Daily, 5 days on / 2 off
Anela's original protocol calls for 3 small injections close together, but most Reddit users prefer a single injection — less pain, same reported results.
GLOW Protocol (GHK-Cu + BPC-157 + TB-500)
Adds TB-500 (Thymosin Beta 4) to the mix for enhanced tissue repair and anti-inflammation.
| Peptide | Dose per Injection | Role |
|---|
| GHK-Cu | 1.5–2 mg | Collagen, elastin, skin repair |
| BPC-157 | 300–400 mcg | Tissue healing, reduces sting |
| TB-500 | 300–400 mcg | Anti-inflammatory, muscle recovery |
How People Stack With Tirzepatide
They run as separate injections — tirzepatide once weekly, GHK-Cu daily. One documented protocol from r/Peptides:
Example Full Stack
- Tirzepatide — 5mg every 5 days
- GHK-Cu + BPC-157 — daily subq (GLOW/Anela protocol)
- Additional: Ipamorelin, TB-500, NAD+, MOTS-C (varies by person)
- Topical GHK-Cu — added to moisturizer for face/hands
3. Reconstitution for a 100mg Vial
Your vial is 100mg, which is larger than the standard 50mg or 75mg vials most protocols reference. Here's how to adapt:
GHK-Cu Only (100mg Vial)
Add 5mL bacteriostatic water to the vial.
| Units Drawn | GHK-Cu Dose |
|---|
| 5 units | 1 mg |
| 10 units | 2 mg |
| 15 units | 3 mg |
| 20 units | 4 mg |
At 2mg/day, your 100mg vial lasts 50 days.
Anela Protocol (100mg Vial)
One Reddit user with 100mg vials reported this setup:
- 100mg GHK-Cu + 20mg BPC-157
- Reconstitute with 7mL BAC + 2mL PBS (phosphate buffered saline — helps reduce sting)
- Protocol: 18 units/day = 2mg GHK + 400mcg BPC
4. Pain Management
GHK-Cu stings when injected subcutaneously. This is the #1 complaint across every peptide forum. Here's what works:
What Helps
- Mix with BPC-157 — dramatically reduces sting (this is why Anela protocol is popular)
- Dilute more with BAC water
- Add PBS (phosphate buffered saline)
- Massage gun on site for 2–5 min after
- Inject in fatty areas (stomach, outer thigh)
- Deeper subq injection, further from skin
What Doesn't Help
- Injecting near the same spot repeatedly
- Shallow injections close to skin surface
- Skip the massage gun — lumps and bruises follow
- GHK-Cu alone without BPC (stings significantly more)
5. Safety & Monitoring
Copper Toxicity Risk
GHK-Cu delivers copper ions subcutaneously. With daily use, there's a real risk of copper accumulation. The community advises:
- Take zinc on days you inject GHK-Cu (helps balance copper)
- Monitor copper levels via blood work
- Some recommend GHK basic (non-copper form) for long-term use
- Watch for signs: white spots on fingernails, anxiety, anhedonia
Injection Site Reactions
Common and expected: lumps, bruising, itching for 1–2 days at the injection site. Massage gun after injection significantly helps. Rotate sites.
No Long-Term Safety Data
There are no published studies on the long-term safety of repeated subcutaneous GHK-Cu injection in humans. The community is running an uncontrolled self-experiment.
6. Published Research
Preclinical Evidence (Strong)
Regenerative and Protective Actions of GHK-Cu Key Review
Comprehensive review showing GHK-Cu can up/downregulate ~4,000 human genes. Stimulates collagen, elastin, glycosaminoglycan synthesis. Promotes blood vessel and nerve outgrowth. Anti-inflammatory via NF-κB suppression. Demonstrated tissue repair in skin, lung, liver, bone, stomach. Limitation: Most evidence is in vitro/animal. Written by GHK-Cu's discoverer (commercial interest).
GHK Peptide as Natural Modulator in Skin Regeneration Review
GHK stimulates collagen, elastin, and glycosaminoglycan synthesis. Restores fibroblast vitality after radiation. "Tightens loose skin and improves elasticity, skin density, and firmness, reduces fine lines and wrinkles, reduces photodamage and hyperpigmentation." References controlled studies on aged skin.
Copper Ions Increase Pro-Collagen 1 & Elastin in Human Skin Mechanistic
Human skin explants exposed to copper ions showed: ~100% increase in elastin after 1 day, ~20% increase in pro-collagen 1, and 2–4x increase in TGF-β1. Clinical studies on copper oxide textiles showed reduced facial wrinkles and enhanced skin elasticity. Most direct evidence for the skin-tightening mechanism.
GHK as Anti-Aging Peptide Review
GHK levels decline from 200 ng/ml at age 20 → 80 ng/ml at age 60. Has anti-inflammatory and tissue remodeling properties. Preliminary evidence of reversing cognitive impairment in aging mice.
GHK-Cu in Acute Lung Injury Animal
GHK-Cu reduced ROS, increased SOD activity, decreased TNF-α and IL-6. Suppressed NF-κB p65 and p38 MAPK signaling in LPS-induced acute lung injury in mice.
GHK-Cu Protects Against Pulmonary Fibrosis Animal
GHK-Cu inhibited inflammatory and fibrotic changes, reduced collagen deposition, and partially prevented epithelial-mesenchymal transition via Nrf2, NF-κB and TGFβ1 pathways in mice.
GHK-Cu Improves ACL Graft Healing in Rats Animal
GHK-Cu improved graft stiffness at 6 weeks (p=0.026) and reduced knee laxity (p=0.009) post-ACLR. But: beneficial effects did not last after treatment was discontinued.
Human Clinical Trials (Limited)
GHK-Cu on CO₂ Laser-Resurfaced Skin Mixed Results
13 patients, randomized. No significant difference in erythema resolution or wrinkle improvement objectively. But: patient satisfaction was significantly higher with GHK-Cu (P=0.04). Subjective benefit, no measurable difference.
GHK-Cu for Venous Stasis Ulcers Negative
86 patients, randomized evaluator-blinded trial. Silver sulfadiazine outperformed GHK-Cu cream for wound healing. No difference between GHK-Cu and placebo.
What's Missing From the Literature
Gaps
- No human trials on subcutaneous GHK-Cu injection for cosmetic skin effects
- No studies on GHK-Cu + GLP-1 combinations at all
- No studies on GHK-Cu for preventing loose skin during weight loss
- No long-term safety data on repeated subq copper peptide injection
- No dose-finding studies for subq administration
- Most strong claims originate from Pickart's group (GHK-Cu discoverer, commercial interest)
7. Honest Verdict
Supported by Evidence
- GHK-Cu stimulates collagen & elastin production (cell/explant studies)
- Copper ions improve skin elasticity in human skin models
- Anti-inflammatory & antioxidant properties (animal studies)
- Topical GHK-Cu may improve subjective skin appearance (one small trial)
- GHK levels naturally decline with age
NOT Supported by Evidence
- Subcutaneous injection for skin tightening (no human studies)
- The 1–2mg/day subq dosing protocol (community consensus only)
- Use alongside GLP-1s for preventing loose skin (no studies)
- Long-term safety of repeated subq copper injection
- Any of the specific blending/stacking protocols
Bottom Line
The biological mechanism is plausible (copper → collagen/elastin production is well-established). The community reports are encouraging. But the specific use case — subcutaneous GHK-Cu alongside GLP-1 drugs for skin tightening during weight loss — has zero clinical trial data. The people reporting great results could be right, but there's no way to know if they would have had the same outcome without it. This is an uncontrolled, community-wide self-experiment.